Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China.
National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China.
Mol Med Rep. 2019 Sep;20(3):2625-2632. doi: 10.3892/mmr.2019.10496. Epub 2019 Jul 12.
MicroRNAs (miRNAs) are small, noncoding RNAs that are ~22 nucleotides in length. Accumulating evidence has revealed that miRNAs act as oncogenes or tumor suppressors in various human cancers. In order to investigate the role of miR‑195‑ in squamous cell lung cancer (SQCLC) cells, and to determine the underlying mechanism, the present study utilized RT‑qPCR, western blot analysis, luciferase assay, MTT assay, cell migration assay, and in vitro angiogenesis techniques. The results obtained revealed that miR‑195‑5p acted as a tumor suppressor in SQCLC cells. The expression levels of miR‑195 were decreased in two SQCLC cell lines (H520 and SK‑Mes‑1) compared with a normal lung cell line, and miR‑195 directly targeted the 3'‑untranslated region of vascular endothelial growth factor (VEGF) in SQCLC cells. Additionally, miR‑195 upregulation suppressed the viability and migration of SQCLC cells. Furthermore, miR‑195 inhibited the growth and tube formation of endothelial vascular cells. Collectively, the findings indicated that miR‑195 downregulated VEGF, and that targeting this miRNA may provide an effective approach to inhibit angiogenesis in tumors.
微小 RNA(miRNA)是长度约为 22 个核苷酸的小非编码 RNA。越来越多的证据表明,miRNA 在各种人类癌症中作为癌基因或肿瘤抑制因子发挥作用。为了研究 miR-195 在鳞状细胞肺癌(SQCLC)细胞中的作用,并确定其潜在机制,本研究利用 RT-qPCR、western blot 分析、荧光素酶测定、MTT 测定、细胞迁移测定和体外血管生成技术进行了研究。结果表明,miR-195-5p 在 SQCLC 细胞中作为肿瘤抑制因子发挥作用。与正常肺细胞系相比,在两种 SQCLC 细胞系(H520 和 SK-Mes-1)中 miR-195 的表达水平降低,并且 miR-195 直接靶向 SQCLC 细胞中血管内皮生长因子(VEGF)的 3'-非翻译区。此外,miR-195 的上调抑制了 SQCLC 细胞的活力和迁移。此外,miR-195 抑制了内皮血管细胞的生长和管形成。综上所述,研究结果表明 miR-195 下调了 VEGF,靶向该 miRNA 可能为抑制肿瘤血管生成提供一种有效方法。